Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2016 2
2018 1
2019 3
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring.
Wasserbauer M, Hlava S, Drabek J, Stovicek J, Minarikova P, Nedbalova L, Drasar T, Zadorova Z, Dolina J, Konecny S, Kojecky V, Kozeluhova J, Cernikova P, Pichlerova D, Kucerova B, Coufal S, Keil R. Wasserbauer M, et al. Among authors: kozeluhova j. PLoS One. 2022 Aug 8;17(8):e0271299. doi: 10.1371/journal.pone.0271299. eCollection 2022. PLoS One. 2022. PMID: 35939424 Free PMC article.
Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
Duricova D, Dvorakova E, Hradsky O, Mitrova K, Durilova M, Kozeluhova J, Kohout P, Zarubova K, Bronsky J, Hradska N, Bronska E, Adamcova M, Machkova N, Hruba V, Bortlik M, Lukas M, Malickova K, Lukas M. Duricova D, et al. Among authors: kozeluhova j. Inflamm Bowel Dis. 2019 Mar 14;25(4):789-796. doi: 10.1093/ibd/izy294. Inflamm Bowel Dis. 2019. PMID: 30239799 Clinical Trial.
Fecal Microbial Transplantation versus Mesalamine Enema for Treatment of Active Left-Sided Ulcerative Colitis-Results of a Randomized Controlled Trial.
Březina J, Bajer L, Wohl P, Ďuricová D, Hrabák P, Novotný A, Koželuhová J, Lukáš M, Mrázek J, Fliegerová KO, Kvasnová S, Chahrazed M, Mareš J, Špičák J, Drastich P. Březina J, et al. Among authors: kozeluhova j. J Clin Med. 2021 Jun 22;10(13):2753. doi: 10.3390/jcm10132753. J Clin Med. 2021. PMID: 34206663 Free PMC article.
Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis.
Keil R, Wasserbauer M, Zádorová Z, Hajer J, Drastich P, Wohl P, Beneš M, Bojková M, Svoboda P, Konečný M, Falt P, Vaňásek T, Pešta M, Pešek F, Bouchner L, Koželuhová J, Novotný A, Bartůsková L, Špičák J. Keil R, et al. Among authors: kozeluhova j. Scand J Gastroenterol. 2016 Sep;51(9):1062-8. doi: 10.3109/00365521.2016.1149883. Epub 2016 Mar 22. Scand J Gastroenterol. 2016. PMID: 27002981 Free PMC article.
Acute portal vein thrombosis in noncirrhotic patients - different prognoses based on presence of inflammatory markers: a long-term multicenter retrospective analysis.
Keil R, Koželuhová J, Dolina J, Hep A, Kroupa R, Kojecký V, Krejčí T, Havlín J, Hadačová I, Segethová J, Koptová P, Zádorová Z, Matouš J, Frýbová B, Chmátal P, Wasserbauer M, Šťovíček J, Bae M, Guven T, Zaeem M, Hlava Š. Keil R, et al. Among authors: kozeluhova j. Scand J Gastroenterol. 2019 Nov;54(11):1379-1384. doi: 10.1080/00365521.2019.1677768. Epub 2019 Oct 19. Scand J Gastroenterol. 2019. PMID: 31630579
13 results